Other OTC - Delayed Quote • USD
Satellos Bioscience Inc. (MSCLF)
At close: April 18 at 10:03 AM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Sep 2022) | Next Qtr. (Dec 2022) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -0.05 | 0 | -0.18 | -0.1 |
Low Estimate | -0.05 | 0 | -0.18 | -0.1 |
High Estimate | -0.05 | 0 | -0.18 | -0.1 |
Year Ago EPS | -- | -- | -- | -0.18 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Sep 2022) | Next Qtr. (Dec 2022) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -- | -- | 100k | -- |
Low Estimate | -- | -- | 100k | -- |
High Estimate | -- | -- | 100k | -- |
Year Ago Sales | -- | -- | -- | 100k |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | ||||
---|---|---|---|---|
EPS Est. | -- | -- | -- | -- |
EPS Actual | -- | -- | -- | -- |
Difference | -- | -- | -- | -- |
Surprise % | -- | -- | -- | -- |
EPS Trend
CURRENCY IN USD | Current Qtr. (Sep 2022) | Next Qtr. (Dec 2022) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
Current Estimate | -0.05 | 0 | -0.18 | -0.1 |
7 Days Ago | -0.05 | 0 | -0.18 | -0.1 |
30 Days Ago | -0.05 | 0 | -0.18 | -0.1 |
60 Days Ago | -0.05 | 0 | -0.18 | -0.1 |
90 Days Ago | -0.05 | 0 | -0.18 | -0.1 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Sep 2022) | Next Qtr. (Dec 2022) | Current Year (2022) | Next Year (2023) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | MSCLF | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 0.80% |
Next Qtr. | -- | -- | -- | 9.60% |
Current Year | -- | -- | -- | 4.50% |
Next Year | 44.40% | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker
Related Tickers
EPRX Eupraxia Pharmaceuticals Inc.
2.5100
-4.92%
EPRX.TO Eupraxia Pharmaceuticals Inc.
3.6900
+2.50%
MBCOF Marvel Biosciences Corp.
0.1043
0.00%
XP0.F Xenon Pharmaceuticals Inc.
37.60
-3.59%
MBXBF Microbix Biosystems Inc.
0.2578
0.00%
LIPO Lipella Pharmaceuticals Inc.
0.7133
-0.01%
SBM.V Sirona Biochem Corp.
0.0650
0.00%
ENGN enGene Holdings Inc.
14.17
-9.97%
NGEN.V NervGen Pharma Corp.
2.0000
+1.01%
ANEB Anebulo Pharmaceuticals, Inc.
2.8500
-1.38%